Replimune Group
REPL
53 hedge funds and large institutions have $287M invested in Replimune Group in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 3 closing their positions.
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
1.37% more ownership
Funds ownership: 60.45% → 61.82% (+1.4%)
0% more funds holding
Funds holding: 53 → 53 (0)
2% less capital invested
Capital invested by funds: $291M → $287M (-$4.81M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.7M |
| 2 |
Goldman Sachs
New York
|
+$1.19M |
| 3 |
BlackRock
New York
|
+$1.11M |
| 4 |
State Street
Boston,
Massachusetts
|
+$944K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$528K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$671K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$345K |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$223K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$143K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$72.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIP
51
Ameritas Investment Partners
Lincoln,
Nebraska
| $9K | – | – | – |
|
|
PCM
52
Prelude Capital Management
New York
| $7K | +$7.3K | +505 | New |
|
53
Daiwa Securities Group
Tokyo,
Japan
| $3K | – | – | – |
|
|
54
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$345K | -22,693 | Closed |
|
55
UBS Group
Zurich,
Switzerland
| – | -$16K | -1,058 | Closed |
|
|
TRCT
56
Tower Research Capital (TRC)
New York
| – | -$12K | -821 | Closed |
|
REPL Hedge Fund Activity: Q2 2019 in Review
53 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q2 2019, worth a combined $287M — down 1.7% from $291M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new REPL positions and 3 closed out — a net gain of 2 holders — while 19 added to existing stakes and 11 trimmed.
The largest buyer was BVF Inc, adding an estimated $1.7M. The largest seller was Fidelity Investments, cutting an estimated $671K.
- 53 institutional investors held Replimune Group (REPL) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $287M of Replimune Group stock for Q2 2019, down 1.7% quarter-over-quarter.
- 5 funds opened new Replimune Group positions in Q2 2019 and 3 closed out, a net change of +2 holders.
- The largest Replimune Group buyer in Q2 2019 was BVF Inc, an estimated $1.7M added.
- The largest Replimune Group seller in Q2 2019 was Fidelity Investments, an estimated $671K sold.
Based on aggregated 13F filings for Q2 2019.